New hope for rare lung cancer: immunotherapy plus chemo shows promise

NCT ID NCT05470595

First seen Jan 09, 2026 · Last updated May 13, 2026 · Updated 13 times

Summary

This study is for people with a rare and advanced type of lung cancer called large-cell neuroendocrine carcinoma. It tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help patients live longer and control the cancer better. About 67 participants will receive the combination treatment to see if it is safe and effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asklepios Fachkliniken München-Gauting

    Gauting, 82131, Germany

  • Charité - Universitätsklinikum Berlin Centrum 12, Medizinische Klinik

    Berlin, 10117, Germany

  • Evangelische Lungenklinik

    Berlin, 12125, Germany

  • Klinikum der J.W. Goethe Universität, Medizinische Klinik II

    Frankfurt am Main, 60590, Germany

  • Klinikum der Johannes Gutenberg Universität, III. Med. Klinik und Poliklinik

    Mainz, 55131, Germany

  • Klinikum der Universität zu Köln, Klinik I für Innere Medizin

    Cologne, 50937, Germany

  • Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH

    Halle, 06110, Germany

  • LungenClinic Grosshansdorf GmbH

    Großhansdorf, 22927, Germany

  • Lungenfachklinik Immenhausen

    Immenhausen, 34376, Germany

  • Lungenklinik Hemer des Deutschen Gemeinschafts-Diakonieverbandes GmbH

    Hemer, 58675, Germany

  • Pius Hospital, Klinik für Hämatologie und Onkologie

    Oldenburg, 26121, Germany

  • Rems-Murr-Klinikum Winnenden, Klinik für Hämatologie, Onkologie und Palliativmedizin

    Winnenden, 71364, Germany

  • Robert-Bosch-Krankenhaus GmbH

    Stuttgart, 70376, Germany

  • Thoraxklinik Heidelberg gGmbH, Universitätsklinikum Heidelberg

    Heidelberg, 69126, Germany

  • Universitätsklinikum Dresden, Medizinische Klinik 1

    Dresden, 01307, Germany

Conditions

Explore the condition pages connected to this study.